Blencowe Resources: Aspiring to become one of the largest graphite producers in the world. Watch the video here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Indeed Bermuda. Next step is a main LSE listing or a listing in the USA.
We should know which by this time next year.
I didn’t see that cardboard wall wobble once.
Agree excellent video, LD seems confident especially around Modi-1, SCIB1 and i SCIB1+.
So data Q3/Q4 - based on body language, I would hazard a guess that it’ll be Q4 for those. Interesting that the GlymAbs seem to be being explored in the ADC space - will be interesting to see what companies are hot in that area.
berm, you may be better placed to answer this but was there a slip of the tongue when she said cytokeratin being one of the targets for Moditope? Or is that in modi-2?
Bazookajr,
Excellent, thanks for the link.
My thoughts exactly Bermuda, best performance I have seen from LD, very upbeat and reassuring.
Bazookajr
Thanks for that. Excellent interview - probably the best yet. Not easy in such a short space of time to explain the complexities and potential of the whole portfolio and I thought she pitched it at just the right level. Also for those who were concerned, Scancell clearly have no intention of delisting.
Scancell's CEO discusses her company's cancer immunotherapy programs
https://www.biotechtv.com/post/scancell-may-3-2024
Me and Inan coming to agreement and AB getting 11 recs within a couple of days, who’d have thought.
Perhaps reality in finally starting to set in.
Word soup Ray? Must be Gaz-pacho.
Scancell have posted the following on their linkedin:-
May is melanoma and skin cancer awareness month, a time to raise awareness about the dangers of hashtag#melanoma and its symptoms, as well as shine a light on all those who contribute to pioneering hashtag#research into its cause, prevention and treatment.
Over the next month, we will be sharing some information on the science behind melanoma, common symptoms and how Scancell Ltd’s novel therapeutic approach has the potential to provide better treatment options to patients living with metastatic melanoma.
https://www.aacr.org/patients-caregivers/awareness-months/melanoma-and-skin-cancer-awareness-month/
Https://www.google.com/search?q=Radio+5+Live+interview+-+cancer+vaccine+research+at+The+Clatter...&ie=UTF-8&oe=UTF-8&hl=en-gb&client=safari#fpstate=ive&vld=cid:0c330470,vid:eToDmmja2xk,st:0
Thanks for your kind words Balerno2 as you look into what I post . May I share this
Christian ottenmeiser
8 minutes in v interesting interview with Christian Ottenmeiser 26 th of April the time the news was buzzing with Moderna
( everyone missed I pointed out the Times changes it’s headline to “bespoke vaccine “ from I think hard to treat melanoma “
Christian ottenmeiser , Sarah Danson and heather shaw are all involved in some chief investigative capacity with the current Scancell trials
Would like your opinion Balernio ? Have a good listen
I consider the upstart Scancell under prof Lindy Durrant were always fire runners
youtube.comBBC Radio 5 Live interview - cancer vaccine research at The Clatter...
Hi cleaner,
Your posts are always inciteful..
This conference pushes BioNTech mRNA personalisation technology which with Moderna is throwing lots of loot at their tech. At what point do they use their muscle to remove the upstart sclp?
The approaches are complementary but we have two massive bios who in effect control the market and the mood music. It will come at a price unless posters here continue to degrade the SP.
Remember sclp owns patent protected platforms.
There much development work to be done which requires cash.
Carpe Diem!
Stakis,
Your 11.28
If anyone over there (with a few notable exceptions) REALLY did understand the science it seems they don't get the INVESTING side as they seem to have spent a great many years telling everyone that "the" RNS is due, "any day now".
Since they have failed to see "The" RNS that was predicted, which will skyrocket SCLP to £8 per share, it appears they've been waiting 11 years for their ideal exit, although they'll all come up with reasons why they are right (Irrespective of the irrefutable proof that to date they are not).
I say 11 years rather than 12 because of the cash raise in 2013 (@ 22.5p a substantial discount to the previous day's closing price) that finally wiped out any near term prospect of a return to the dizzy heights of the 2012 (64p - BEFORE the mass dilution - which followed over the ensuing (almost) 11 years).
So it seems a relatively straightforward but obvious conclusion that many of the "experts" over there do not have the global view of the Biotech industry (or even a passing acquaintance ) with the commercial situation in the Biotech industry which would have been helpful in making Scancell an investment which could have been profitable and that, or some of that profit, secured in 2012.
Now THAT would have been a great investment. Many are now left with a break even in 2024 which (IMO) cannot be claimed as a brilliant strategy. Many watched their holding swing from significant profit to their current position by following the Scientific "Experts" on BBs.
Buying and blindly holding has clearly been not been the stellar moneymaking process that so many trumpeted year in year out. It's a shame but irrefutable.
Anyone who has taken the decision to disinvest at the many opportunities which have arisen over the years have generally been "ridiculed" for their decision, even though most of those who have sold have generally been able to reinvest at a lower level given the passage of time whilst recovering some (or all) of their initial investment.
I'm sure there's a few realists on this BB who would agree. Fewer over on the other side (or however the divide is described) and maybe there will be howls of protest that my comments aren't valid or even born of malice. They are neither. There will be people who have profited from Scancell over the years, but it won't be those who have followed the "expert" advice of those who are most vociferous (and often outrageously wrong) on not only this, but other BBs.
AIMO
Seems a few on here haven’t just looked into the abyss, they’ve fell in recently.
🤣🤣🤣🤣
Absolutely no need to talk about ruck in that manner!
Don't worry Stakis, neither does the madman over there. Just a soup of words.
🤣
Stakis, I see you found it ....and looked into the abyss 🤣
I'm sure it's just a rumour going around, but is it true that inan and ruck have agreed on something?
No mention of it on the BBC website.
I guess some folk just love to whinge!
https://www.youtube.com/watch?v=ZqLT3PmOKtQ
Christ I thought this board was disharmonious - nothing compared to that. Far too detailed for me - I wouldn't even pretend to understand the science behind Scancell or even the maths behind the ORR % calculations. Think I'll stick to this board!!
No need just register to read the pile of nonsense from insnaco and others.
Hi Stakis - the forum is free.
Presume you have to upgrade (and pay!!!) to read the forum.
50p for a cup of tea. That will be nice however will not make a lots of difference if that comes by the time we are in a care home being looked after by folks who can’t speak the lingo.